U.S. markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.09
    +0.45 (+0.99%)
     
  • Gold

    1,842.00
    +0.90 (+0.05%)
     
  • Silver

    24.32
    +0.18 (+0.76%)
     
  • EUR/USD

    1.2127
    -0.0022 (-0.18%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • GBP/USD

    1.3438
    -0.0015 (-0.11%)
     
  • USD/JPY

    104.1400
    +0.2800 (+0.27%)
     
  • BTC-USD

    19,048.74
    +0.45 (+0.00%)
     
  • CMC Crypto 200

    365.19
    -14.05 (-3.71%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Blueprint Medicines Corp (BPMC) CEO and President Jeffrey W. Albers Sold $2 million of Shares

GuruFocus.com
·2 min read

- By insider

CEO and President of Blueprint Medicines Corp (30-Year Financial, Insider Trades) Jeffrey W. Albers (insider trades) sold 20,000 shares of BPMC on 11/16/2020 at an average price of $98.71 a share. The total sale was $2 million.


Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include avapritinib, BLU 554, BLU-782 and BLU-667. Blueprint Medicines Corp has a market cap of $5.32 billion; its shares were traded at around $95.44 with a P/E ratio of 17.62 and P/S ratio of 6.62. GuruFocus has detected 2 severe warning signs with Blueprint Medicines Corp. .

CEO Recent Trades:

  • CEO and President Jeffrey W. Albers sold 20,000 shares of BPMC stock on 11/16/2020 at the average price of $98.71. The price of the stock has decreased by 3.31% since.

Directors and Officers Recent Trades:

  • COO Kate Haviland sold 409 shares of BPMC stock on 11/16/2020 at the average price of $100.27. The price of the stock has decreased by 4.82% since.

  • Principal Accounting Officer Ariel Hurley sold 1,700 shares of BPMC stock on 11/16/2020 at the average price of $100.92. The price of the stock has decreased by 5.43% since.

  • Chief Commercial Officer Christina Rossi sold 345 shares of BPMC stock on 11/03/2020 at the average price of $99.69. The price of the stock has decreased by 4.26% since.

  • Director Charles A Rowland Jr sold 10,000 shares of BPMC stock on 11/03/2020 at the average price of $98.9. The price of the stock has decreased by 3.5% since.

For the complete insider trading history of BPMC, click here

.This article first appeared on GuruFocus.